Kyverna Therapeutics, Inc. (KYTX)
7.655
0.00 (0.00%)
USD |
NASDAQ |
Jun 11, 09:50
Kyverna Therapeutics Total Assets (Quarterly) : 257.02M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 257.02M |
| December 31, 2025 | 294.95M |
| September 30, 2025 | 187.16M |
| June 30, 2025 | 226.51M |
| March 31, 2025 | 260.66M |
| December 31, 2024 | 306.52M |
| September 30, 2024 | 339.20M |
| Date | Value |
|---|---|
| June 30, 2024 | 363.12M |
| March 31, 2024 | 389.98M |
| December 31, 2023 | 75.20M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 66.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| X4 Pharmaceuticals, Inc. | 270.28M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.179B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 61.44M |
| Shareholders Equity (Quarterly) | 195.58M |
| Debt to Equity Ratio | 0.1726 |
| Current Ratio | 8.146 |
| Net Debt Paydown Yield | -0.98% |